| International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project (NCT05387811) | Azienda Ospedaliera di Padova | 2022-07-01 |
| The Selective Cytopheretic Device (SCD) for Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I (NCT04898010) | Lenar Yessayan | 2022-06-09 |
| Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury (NCT05434286) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2021-12-15 |
| Angiotensin 2 for Hepatorenal Syndrome (NCT04048707) | University of California, Los Angeles | 2021-07-01 |
| Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE) (NCT04460560) | University of Pennsylvania | 2020-12-11 |
| Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure. (NCT04416282) | Institute of Liver and Biliary Sciences, India | 2020-06-22 |
| Korean Cohort Study of AKI & HRS in Cirrhosis (NCT03530761) | Soonchunhyang University Hospital | 2017-08-01 |
| Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1 (NCT02770716) | Mallinckrodt | 2016-07-13 |
| Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure (NCT01587222) | Anna Cruceta | 2016-07-01 |
| The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure (NCT02489864) | Sun Yat-sen University | 2015-07-01 |
| Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg (NCT02789150) | University of Louisville | 2015-01-01 |
| Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline (NCT02123576) | Patrick Northup, MD | 2014-04-01 |
| Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury (NCT02097784) | Hospices Civils de Lyon | 2014-03-01 |
| Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis (NCT02049125) | University of Sao Paulo | 2013-06-01 |
| Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis (NCT01932151) | Hospital Clinic of Barcelona | 2012-12-01 |
| To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome (NCT01649037) | Institute of Liver and Biliary Sciences, India | 2012-08-01 |
| Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients (NCT02434445) | The University of Hong Kong | 2012-06-01 |
| Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients (NCT01436500) | Cumberland Pharmaceuticals | 2011-10-01 |
| A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin (NCT01143246) | Mallinckrodt | 2010-10-11 |
| Single Pass Albumin Dialysis in Patients With Cirrhosis (NCT00764049) | Assistance Publique - Hôpitaux de Paris | 2009-06-01 |
| Noradrenalin vs Terlipressin in Hepatorenal Syndrome (NCT00370253) | University of Turin, Italy | 2006-09-01 |
| Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome (NCT00742339) | University of Padova | 2005-05-01 |
| Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome (NCT00734136) | Lahey Clinic | 2005-05-01 |
| Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1 (NCT00089570) | Mallinckrodt | 2004-06-01 |
| Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin (NCT00287664) | Hospital Clinic of Barcelona | 2002-02-01 |
| Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis (NCT00359853) | Hospital Clinic of Barcelona | 2000-09-01 |